i-Base home
Search Menu
  • Home
  • HTB
  • 2019
  • December

December 2019

Contents

Editorial

  • i-Base 2019 appeal: we need your help….
  • HTB 13 December 2019 online

Supplements

  • Introduction to ART – October 2019
  • UK Guide to PrEP – November 2019

Conference reports

  • 17th European AIDS Conference (EACS 2019)
  • Capsid inhibitor GS-6207 (lenacapavir): potential for 6 monthly dosing for MDR HIV
  • Dolutegravir/lamivudine as dual ART
  • Weight changes with doravirine-based first line therapy
  • Bone and renal changes in the ADVANCE trial
  • 10th International Workshop on HIV and Ageing
  • Impact of isolation and loneliness on older people living with HIV

Antiretrovirals

  • Doravirine approved by NHS England as single NNRTI and as part of FDC with 3TC/TDF
  • Fostemsavir submitted to US FDA for multidrug resistant HIV
  • Paediatric dispersible formulation of dolutegravir submitted to EMA and FDA

Weight, diabetes, metabolic complications

  • Tesamorelin for NAFLD in people living with HIV

PDFs

  • 13 December 2019 vol 20 no 14
  • HTB RSS

Early access

  • US CDC updated guidelines on PEP (May 2025) 10 May 2025
  • Closed clinics and limited ART in Zimbabwe, PEPFAR and UNAIDS news 4 May 2025
  • The RIO study: Q&A about controlling HIV with bNAbs 21 April 2025
  • Lenacapavir EAP in the UK closed to new referrals: NHS England and Gilead fail to agree a price after more than two years 20 April 2025
  • All early access reports

Current issues

  • May 2025
  • April 2025
  • March 2025
  • Back issues

Special report

  • Reduced dosing: a possible crisis response to ART stockouts and closed clinics 5 May 2025

More from HTB

  • Conference reports
  • Conference shortcuts
  • Articles by subject
  • PDFs
  • Subscribe
  • HTB homepage

Home

  • i-Base homepage
  • Donate

This website sets no cookies from us or anyone else.

Information on this website is provided by treatment advocates and offered as a guide only. Decisions about your treatment should always be taken in consultation with your doctor.

HIV i-BASE
About us - Contact - Cookies and privacy - Copyright waiver - Terms of use - Home
Registered charity number: 1081905. Company number: 3962064.

Search i-Base

Site navigation

Quick links
HIV positive
Donate
Feedback
Advice and information
Q and A
Guides
HIV meds
Glossary
Research reports
HTB
HTB South
Pipeline report
Publications and resources
Publications
Other resources
Translations
Slide sets
Order and subscribe
Advocates' network
UK-CAB
Training manual
i-Base
About us
Contact
News and updates
Sitemap
Home
Find us on Facebook
i-Base on Facebook